Patent details

EP1605952 Title: USE OF 5-SUBSTITUTED NUCLEOSIDES FOR REINFORCING THE APOPTOTIC EFFECT OF CYTOSTATIC DRUGS

Basic Information

Publication number:
EP1605952
PCT Application Number:
PCT/EP/2003/013008
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP038164331
PCT Publication Number:
WO/2004/084917
First applicant's nationality:
Translation Language:
EPO Publication Language:
German
English Title of Invention:
USE OF 5-SUBSTITUTED NUCLEOSIDES FOR REINFORCING THE APOPTOTIC EFFECT OF CYTOSTATIC DRUGS
French Title of Invention:
UTILISATION DE NUCLEOSIDES SUBSTITUÉS EN 5 POUR RENFORCER L'EFFET APOPTOTIQUE DE CYTOSTATIQUES
German Title of Invention:
VERWENDUNG VON 5-SUBSTITUIERTEN NUKLEOSIDEN ZUR VERSTÄRKUNG DER APOPTOTISCHEN WIRKUNG VON ZYTOSTATIKA
SPC Number:

Dates

Filing date:
20/11/2003
Grant date:
02/05/2007
EP Publication Date:
02/05/2007
PCT Publication Date:
07/10/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/12/2005
EP B1 Publication Date:
02/05/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/11/2007
Expiration date:
20/11/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/11/2003
 
 

Name:
Resprotect GmbH
Address:
Fieldstrasse 34, 01307 Dresden, Germany (DE)

Inventor

1

Name:
FAHRIG Rudolf
Address:
Germany (DE)

2

Name:
HEINRICH Jörg-Christian
Address:
Germany (DE)

3

Name:
KRUPITZA Georg
Address:
Austria (AT)

Priority

Priority Number:
10313035
Priority Date:
24/03/2003
Priority Country:
Germany (DE)

Classification

Main IPC Class:
A61K 31/7072;
Filing date Document type Number of pages